COMP <GO>
LIFE vs BRK-B // NET PROFIT MARGIN
Ethos Technologies Inc. (Class A) (NASDAQ) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: LIFE 3
— BRK-B 7
▲ NET PROFIT MARGIN LEADER: BRK-B
LAST: $43.39 (-0.53%) • MKT CAP: $2.83B
net-margins
18.40%
LAST: $542.49 (+0.10%) • MKT CAP: $1.20T
net-margins
22.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LIFE VS. BRK-B)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LIFE | BRK-B | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 40.60% | 11.47% | +29.13 | LIFE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 37.0x | 9.7x | +27.32 | BRK-B | /valuation <GO> |
| Free Cash Flow Yield | 1.23% | 2.09% | -0.86 | BRK-B | /fcf-yield <GO> |
| Operating Margin | 18.80% | 27.80% | -9.00 | BRK-B | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 18.40% | 22.30% | -3.90 | BRK-B | /net-margins <GO> |
| Revenue Growth (YoY) | 52.00% | 3.93% | +48.07 | LIFE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 2.85 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 4/9 | +2.00 | LIFE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 3.55% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.8 | 67.7 | -1.90 | BRK-B | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.61 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.4x | 24.3x | +9.06 | BRK-B | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.83B | $1.20T | -$1.19T | BRK-B | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LIFE REV | BRK-B REV | LIFE GROSS % | BRK-B GROSS % | LIFE FCF | BRK-B FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $387.6M | $371.44B | — | — | $34.7M | $25.04B |
| FY 2024 | $254.9M | $371.43B | — | — | -$11.7M | $11.62B |
| FY 2023 | — | $364.48B | — | — | — | $29.79B |
| FY 2022 | — | $302.02B | — | — | — | $21.89B |
| FY 2021 | — | $276.19B | — | — | — | $26.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LIFE // BETA —
BRK-B // BETA 0.61